American Journal of Epidemiology Advance Access originally published online on August 24, 2005
American Journal of Epidemiology 2005 162(7):705; doi:10.1093/aje/kwi267
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
American Journal of Epidemiology Copyright © 2005 by the Johns Hopkins Bloomberg School of Public Health All rights reserved
LETTERS TO THE EDITOR |
MACALUSO ET AL. REPLY
1 Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341-3724
2 Center for Epidemiology and Biostatistics, Children's Hospital Medical Center, Cincinnati, OH 45229-3039
| The first 10% of the full text of this article appears below. |
Zaviacic and Ablin (1
) suggest that assessment of semen exposure based on pre- and postcoital measurement of prostate-specific antigen (PSA) in vaginal fluid is not valid for evaluating condom effectiveness (2
, 3
). We disagree for two reasons: 1) in the absence of semen exposure, the small amount of PSA produced by the female paraurethral glands would yield PSA values below the
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. M. Minnis, M. J. Steiner, M. F. Gallo, L. Warner, M. M. Hobbs, A. van der Straten, T. Chipato, M. Macaluso, and N. S. Padian Biomarker Validation of Reports of Recent Sexual Activity: Results of a Randomized Controlled Study in Zimbabwe Am. J. Epidemiol., October 1, 2009; 170(7): 918 - 924. [Abstract] [Full Text] [PDF] |
||||
